{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:30:05Z","timestamp":1694637005264},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s12519-009-0059-5","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T02:42:56Z","timestamp":1257993776000},"page":"308-311","source":"Crossref","is-referenced-by-count":5,"title":["Drugs controlling proteinuria of patients with Alport syndrome"],"prefix":"10.1007","volume":"5","author":[{"given":"Jian-Guo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,13]]},"reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"C.E. Kashtan","year":"1998","unstructured":"Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 1998;9:1736\u20131750.","journal-title":"J Am Soc Nephrol"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0272-6386(96)90512-0","volume":"27","author":"C. Burton","year":"1996","unstructured":"Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765\u2013775.","journal-title":"Am J Kidney Dis"},{"key":"59_CR3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s004310051301","volume":"159","author":"W. Proesmans","year":"2000","unstructured":"Proesmans W, Knockaert H, Trouet D. Enalapril in paediatric patients with Alport syndrome: 2 years\u2019 experience. Eur J Pediatr 2000;159:430\u2013433.","journal-title":"Eur J Pediatr"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0272-6386(96)90540-5","volume":"27","author":"E.P. Cohen","year":"1996","unstructured":"Cohen EP, Lemann J Jr. In hereditary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression. Am J Kidney Dis 1996;27:199\u2013203.","journal-title":"Am J Kidney Dis"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00467-003-1366-z","volume":"19","author":"W. Proesmans","year":"2004","unstructured":"Proesmans W, Van Dyck M. Enalapril in children with Alport syndrome. Pediatr Nephrol 2004;19:271\u2013275.","journal-title":"Pediatr Nephrol"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","volume":"63","author":"O. Gross","year":"2003","unstructured":"Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, et al. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 2003;63:438\u2013446.","journal-title":"Kidney Int"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00467-006-0270-8","volume":"21","author":"H. Kaito","year":"2006","unstructured":"Kaito H, Nozu K, Iijima K, Nakanishi K, Yoshiya K, Kanda K, et al. The effect of aldosterone blockade in patients with Alport syndrome. Pediatr Nephrol 2006;21:1824\u20131829.","journal-title":"Pediatr Nephrol"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00467-006-0227-y","volume":"22","author":"M. Charbit","year":"2007","unstructured":"Charbit M, Gubler MC, Dechaux M, Gagnadoux MF, Gr\u00fcnfeld JP, Niaudet P. Cyclosporin therapy in patients with Alport syndrome. Pediatr Nephrol 2007;22:57\u201363.","journal-title":"Pediatr Nephrol"},{"key":"59_CR9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/00365590600830417","volume":"40","author":"T.S. Sigmundsson","year":"2006","unstructured":"Sigmundsson TS, Palsson R, Hardarson S, Edvardsson V. Resolution of proteinuria in a patient with X-linked Alport syndrome treated with cyclosporine. Scand J Urol Nephrol 2006;40:522\u2013525.","journal-title":"Scand J Urol Nephrol"},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s004670050166","volume":"10","author":"W. Proesmans","year":"1996","unstructured":"Proesmans W, Wambeke IV, Dyck MV. Long-term therapy with enalapril in patients with nephrotic-range proteinuria. Pediatr Nephrol 1996;10:587\u2013589.","journal-title":"Pediatr Nephrol"},{"key":"59_CR11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"J.P. Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000;11:649\u2013657.","journal-title":"J Am Soc Nephrol"},{"key":"59_CR12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1523-1755.1999.0550031051.x","volume":"55","author":"L. Call\u00eds","year":"1999","unstructured":"Call\u00eds L, Vila A, Carrera M, Nieto J. Long-term effects of cyclosporine A in Alport\u2019s syndrome. Kidney Int 1999;55: 1051\u20131056.","journal-title":"Kidney Int"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.ASN.0000046964.15831.16","volume":"14","author":"D. Chen","year":"2003","unstructured":"Chen D, Jefferson B, Harvey SJ, Zheng K, Gartley CJ, Jacobs RM, et al. Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol 2003;14:690\u2013698.","journal-title":"J Am Soc Nephrol"},{"key":"59_CR14","first-page":"432","volume":"53","author":"G. Lama","year":"2000","unstructured":"Lama G, Luongo I, Piscitelli A, Salsano ME. Enalapril: antiproteinuric effect in children with nephrotic syndrome. Clin Nephrol 2000;53:432\u2013436.","journal-title":"Clin Nephrol"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2369-3-2","volume":"3","author":"L. Adler","year":"2002","unstructured":"Adler L, Mathew R, Futterweit S, Frank R, Gauthier BG, Kashtan CE, et al. Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion. BMC Nephrol 2002;3:2.","journal-title":"BMC Nephrol"},{"key":"59_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00866356","volume":"8","author":"X. Jiang","year":"1994","unstructured":"Jiang X. Clinical observations on the use of the Chinese herb Tripterygium wilfordii Hook for the treatment of nephrotic syndrome. Pediatr Nephrol 1994;8:343\u2013344.","journal-title":"Pediatr Nephrol"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ki.2008.203","volume":"74","author":"C.X. Zheng","year":"2008","unstructured":"Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro. Kidney Int 2008;74:596\u2013612.","journal-title":"Kidney Int"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/ndt\/12.10.2064","volume":"12","author":"M. Sharma","year":"1997","unstructured":"Sharma M, Li JZ, Sharma R, Artero M, Ge X, McCarthy ET, et al. Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro. Nephrol Dial Transplant 1997;12:2064\u20132068.","journal-title":"Nephrol Dial Transplant"},{"key":"59_CR19","first-page":"1094","volume":"26","author":"Y.G. Wan","year":"2006","unstructured":"Wan YG, Sun W, Wang Y, Zhang J, Li M, Ruan JG, et al. Effects of multi-glycoside of Tripterygium wilfordii Hook. f. on proteinuria and expression of slit diaphragm-associated molecules in rats with anti-thy1.1 glomerulonephritis. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2006;26:1094\u20131102. [in Chinese]","journal-title":"Zhong Guo Zhong Xi Yi Jie He Za Zhi"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-009-0059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-009-0059-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-009-0059-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T22:29:36Z","timestamp":1634164176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-009-0059-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s12519-009-0059-5","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}